A successful communication skills training program about clinical trials is expanding to cover pediatric cancer. The workshop trains medical oncology fellows to communicate clearly with patients and their families about the benefits of enrolling in a clinical trial.
“We play a key role in responding to the cancer plan in the state of Florida, especially given the disproportionate burden in our region.” — Ramzi Salloum, Ph.D.
Nine UF Health Cancer Institute researchers have been awarded pilot funding for innovative cancer research projects that aim to advance our understanding of how cancer develops and resists treatment, as well develop novel strategies for preventing cancer and personalizing treatment.
In February, two members of UF Health Cancer Institute will begin their 10-month training program with INCITE (INcreasing Caregiver support Implementation through Training and Education). Carla L. Fisher, Ph.D. a behavioral scientist with a clinical social work background, has teamed with Deidre B. Pereira, Ph.D., a psycho-oncologist.
At-home kits that allow women to collect their own samples for HPV testing have been shown to improve cervical cancer screening rates. But some women lack confidence in their ability to complete the collection themselves.
We celebrate our extensive partnerships with the UF Health Cancer Institute. Several of the Institute's top stories feature our researchers and staff members.
Ramzi Salloum, Ph.D., associate director for community outreach and engagement at the UF Health Cancer Institute, has been elected vice chair of the Florida Cancer Control and Research Advisory Council.
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
Working with oncologists, Carma Bylund, Ph.D., and study first author Naomi Parker, Ph.D., both from the UF Department of Health Outcomes and Biomedical Informatics, are piloting an “information prescription” to steer patients to sources of evidence-based information like the American Cancer Society.
A new study by University of Florida researchers and collaborators has found that a popular class of weight loss drugs is associated with lower cancer risk.
